表紙
市場調査レポート

アジア太平洋地域における原薬(API)市場:中国・インドでの普及率上昇と低コスト生産による域内市場の成長

Active Pharmaceutical Ingredients (APIs) Market in Asia Pacific to 2017 - Increasing Penetration in China and India Coupled with Low Cost Manufacturing to Fuel Regional Growth

発行 GBI Research 商品コード 204889
出版日 ページ情報 英文 95 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.95円で換算しております。
Back to Top
アジア太平洋地域における原薬(API)市場:中国・インドでの普及率上昇と低コスト生産による域内市場の成長 Active Pharmaceutical Ingredients (APIs) Market in Asia Pacific to 2017 - Increasing Penetration in China and India Coupled with Low Cost Manufacturing to Fuel Regional Growth
出版日: 2012年11月09日 ページ情報: 英文 95 Pages
概要

アジア太平洋地域の原薬(API)市場は、2011年の段階で世界全体の28.3%を占めています。2011年に306億9300万米ドルだった同地域の市場収益は、2017年までに年平均(CAGR)5.6%の速度で成長し、2017年には638億米ドルに達する、と予想されています。

当レポートでは、アジア太平洋地域における医薬品原薬(以下API)の市場について調査分析し、同地域全体の市場動向、収益分析と予測(過去7年間の実績値と今後6年間の予測値)、製品別・治療分野別・顧客ベース別(ブランド薬/ジェネリック医薬品)の詳細動向、競合動向とともに、日本、中国、インド、韓国の各国別の市場動向、更に域内での医薬品受託製造機関(CMO)市場の動向などをまとめ、概略以下の構成でお届けします。

第1章 目次

第2章 エグゼクティブ・サマリー

第3章 イントロダクション

第4章 医薬品受託製造機関(CMO)

  • CMOへのアウトソーシングの過程
  • アジア太平洋地域のCMO市場の促進因子
    • 低コストでの熟練労働者の調達可能性
    • アウトソーシングの主な利点
  • 市場収益とその予測(過去・将来6年間の実績値・予測値)

第5章 アジア太平洋地域のAPI市場

  • 業界構造
  • 流通構造
  • 市場概要
  • 市場分類
    • 合成API
    • バイオAPI
  • 市場促進因子
    • 途上国(中国・インドなど)医薬品製造能力の向上
    • 各国の国内市場の成長
    • バイオAPIに対する関心の増大
    • 中国・インドでの監督体制の改善
    • ブロックバスター薬の特許失効
  • 市場阻害因子
    • 特許失効の増加によるブランドAPI市場の成長阻害
    • 非常に細分化された市場
    • 医薬品製造能力の改善の限界
    • 為替レートの乱高下
  • 市場収益とその予測
  • 製品種類別の市場シェア
  • 合成API市場
    • 市場促進因子
    • 市場阻害因子
    • 市場収益とその予測
    • 顧客ベース別の市場シェア
    • 顧客ベース別の市場収益とその予測
  • バイオAPI市場
    • 市場促進因子
    • 市場阻害因子
    • 市場収益とその予測
    • 顧客ベース別の市場シェア
    • 顧客ベース別の市場収益とその予測
  • 代表的な生物製剤の特許失効状況
  • 治療分野別の市場シェア

第6章 日本のAPI市場

  • 市場概要
  • 市場収益とその予測
  • 製品種類別の市場シェア
  • 顧客ベース別の市場(合成/バイオAPIの市場収益・シェア)
  • 治療分野別の市場シェア

第7章 中国のAPI市場

  • 市場概要
  • 市場収益とその予測
  • 製品種類別の市場シェア
  • 顧客ベース別の市場(合成/バイオAPIの市場収益・シェア)
  • 治療分野別の市場シェア

第8章 韓国のAPI市場

  • 市場概要
  • 市場収益とその予測
  • 製品種類別の市場シェア
  • 顧客ベース別の市場(合成/バイオAPIの市場収益・シェア)
  • 治療分野別の市場シェア

第9章 インドのAPI市場

  • 市場概要
  • 市場収益とその予測
  • 製品種類別の市場シェア
  • 顧客ベース別の市場(合成/バイオAPIの市場収益・シェア)
  • 治療分野別の市場シェア

第10章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GBICH0072MR

Abstract

Description

GBI Research's report, "Active Pharmaceutical Ingredients (APIs) - Asia-Pacific Market to 2017", provides a detailed insight into the Asia-Pacific API market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in this region. The report contains market forecasts, product type analysis, drivers and restraints. In addition, it includes therapeutic categories analysis and CMO growth in the region, and its influence on API manufacturing activity towards 2017. Overall, the report presents a comprehensive analysis of the Asia-Pacific API market, covering all of the major parameters. The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research's team of industry experts. Asia-Pacific is the second largest regional market for APIs by revenue in the world. The Asia-Pacific active pharmaceutical ingredients market revenue held a share of around 28.3% of the global API market in 2011, with the global revenue standing at $108,613m. Total revenue generated by the Asia-Pacific API market was $30,693m in 2011, and is expected to grow at a CAGR of 5.6% to reach $63.8 billion by 2017. This will be supported by healthy demand from the biotech and generic API sectors.

Scope

  • Market revenue data for APIs from 2005 to 2011 and forecasts for six years to 2017.
  • API markets in key countries in the region, including Japan, China, South Korea and India.
  • API industry structure and market trends, such as a shift in manufacturing and growth in biotechnology for the Asia-Pacific region.
  • Drivers of the API market, such as the growth of generic drugs, and restraints.
  • Detailed historic and forecast trends and share analysis of API revenue, based on product types (synthetic and biotech APIs) in the Asia-Pacific market, and in key countries of the region.
  • Detailed historic and forecast trends and share analysis of API revenue, based on customer base (generic and innovative for synthetic APIs, biosimilars and biologics for biotech APIs) in the Asia-Pacific market, and in key countries of the region.
  • Analysis of API revenue based on therapeutic categories at a regional and key country level.

Reasons to Buy

  • Develop business strategies with the help of specific insights on the Asia-Pacific API market.
  • Identify opportunities and challenges in the Asia-Pacific API market.
  • Invest in the growing segments of the API market.
  • Increase future revenue and profitability with the help of insights on the future opportunities and critical success factors in the Asia-Pacific API market.
  • Benchmark your operations and strategies against the major players in the global API market.

Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Executive Summary

  • 2.1 Asia-Pacific Active Pharmaceutical Ingredients Market Revenue Expected to Grow, with a Healthy CAGR of 8.5% During the Forecast Period 2011 - 2017
  • 2.2 The Rapidly Increasing Biotech APIs Market Will Challenge the Synthetic Market's Dominance in the Region's APIs Market in Future
  • 2.3 Developing Countries such as China and India Will Lead the Region's APIs Market Demand
  • 2.4 Improving Regulatory Framework Will Boost the APIs Market Growth in Asia-Pacific

3 Introduction

  • 3.1 GBI Report Coverage

4 Contract Manufacturing Organizations (CMO)

  • 4.1.1 Process of CMO Outsourcing
  • 4.2 Asia-Pacific CMO Market Drivers
    • 4.2.1 Availability of Low-cost Skilled Manpower
    • 4.2.2 Key Benefits of Outsourcing
  • 4.3 Asia-Pacific CMO Market Revenues and Forecast to 2017

5 Asia-Pacific Active Pharmaceutical Ingredients Market

  • 5.1 Asia-Pacific API Industry Structure
  • 5.2 Asia-Pacific API Distribution Structure
  • 5.3 Asia-Pacific API Market Overview
  • 5.4 Asia-Pacific APIs Market Segmentation
    • 5.4.1 Synthetic APIs
    • 5.4.2 Biotech APIs
  • 5.5 Asia-Pacific APIs Market Drivers
    • 5.5.1 Growing Pharmaceutical Manufacturing Capabilities of Developing Countries Such as China and India are Attracting APIs Manufacturing from Developed Countries
    • 5.5.2 Domestic Market Growth of Developing Countries in Asia-Pacific is Providing Global Pharmaceutical Industry Growth
    • 5.5.3 Increasing Focus on Biotech API Drugs in Asia-Pacific will Contribute Significantly to Asia-Pacific APIs Market Growth
    • 5.5.4 The Improving Regulatory Framework in Markets of China and India is Increasing the Penetration of Branded Drugs
    • 5.5.5 Patent Expiries of Blockbuster Drugs Boosting the Market Revenues in Asia-Pacific
  • 5.6 Asia-Pacific APIs Market Restraints
    • 5.6.1 Increasing Patent Expiries Hamper the Growth of the Branded API Market
    • 5.6.2 Highly Fragmented Market Restricts the Revenue Growth of the Asia-Pacific API Market
    • 5.6.3 Limited Improvement in Pharmaceutical Manufacturing Capabilities may Hamper Overall Growth Potential
    • 5.6.4 High Currency Fluctuations Hamper the Value Growth of the Pharmaceutical Market in the Asia-Pacific Region
  • 5.7 Asia-Pacific APIs Market Revenue and Forecasts to 2017
  • 5.8 Asia-Pacific Revenue Share Analysis by Product Types
  • 5.9 Asia-Pacific Synthetic APIs Market
    • 5.9.1 Asia-Pacific Synthetic APIs Market Drivers
    • 5.9.2 Asia-Pacific Synthetic APIs Market Restraints
    • 5.9.3 Asia-Pacific Synthetic Market Revenues and Forecast to 2017
    • 5.9.4 Asia-Pacific Synthetic Market Revenue Share Analysis by Consumer Base
    • 5.9.5 Asia-Pacific Synthetic Market Revenues by Customer Base and Forecast to 2017
  • 5.10 Asia-Pacific Biotech APIs Market
    • 5.10.1 Asia-Pacific Biotech APIs Market Drivers
    • 5.10.2 Asia-Pacific Biotech APIs Market Restraints
    • 5.10.3 Asia-Pacific Biotech Market Revenues and Forecasts to 2017
    • 5.10.4 Asia-Pacific Biotech Market Revenue Share Analysis by Customer Base
    • 5.10.5 Asia-Pacific Biotech Market Revenue by Customer Base and Forecast to 2017
  • 5.11 Asia-Pacific Patent Expiry of Leading Biologics
  • 5.12 Asia-Pacific APIs Market Share Analysis by Therapeutic Applications

6 Japan Active Pharmaceutical Ingredients Market

  • 6.1 Japan APIs Market Overview
  • 6.2 Japan APIs Market Revenue and Forecasts to 2017
  • 6.3 Japan APIs Market Revenue Share Analysis by Product Type
  • 6.4 Japan APIs Market by Customer Base
    • 6.4.1 Japan Synthetic Market Revenue by Customer Base and Forecasts to 2017
    • 6.4.2 Japan Synthetic Market Revenue Share Analysis by Customer Base
    • 6.4.3 Japan Biotech Market Revenue by Customer Base and Forecasts to 2017
    • 6.4.4 Japan Biotech Market Revenue Share Analysis by Customer Base
  • 6.5 Japan APIs Market Share Analysis by Therapeutic Applications

7 China Active Pharmaceutical Ingredients Market

  • 7.1 China APIs Market Overview
  • 7.2 China API Market Revenues by Product Type and Forecasts to 2017
  • 7.3 China APIs Market Revenue Share Analysis by Product Types
  • 7.4 China APIs Market by Customer Base
    • 7.4.1 China Synthetic Market Revenue by Customer Base and Forecasts to 2017
    • 7.4.2 China Synthetic Market Revenue Share Analysis by Customer Base
    • 7.4.3 China Biotech Market Revenue by Customer Base and Forecast to 2017
    • 7.4.4 China Biotech Market Revenue Share Analysis by Customer Base
  • 7.5 China APIs Market Share Analysis by Therapeutic Applications

8 South Korea Active Pharmaceutical Ingredients Market

  • 8.1 South Korea APIs Market Overview
  • 8.2 South Korea APIs Market Revenue and Forecasts to 2017
  • 8.3 South Korea APIs Market Revenue Share Analysis by Product Type
  • 8.4 South Korea APIs Market by Customer Base
    • 8.4.1 South Korea Synthetic Market Revenue by Customer Base and Forecasts to 2017
    • 8.4.2 South Korea Synthetic Market Revenue Share Analysis by Customer Base
    • 8.4.3 South Korea Biotech Market Revenue by Customer Base and Forecasts to 2017
    • 8.4.4 South Korea Biotech Market Revenue Share Analysis by Customer Base
  • 8.5 South Korea APIs Market Share Analysis by Therapeutic Applications

9 India Active Pharmaceutical Ingredients Market

  • 9.1 India APIs Market Overview
  • 9.2 India APIs Market Revenue and Forecasts to 2017
  • 9.3 India APIs Market Revenue Share Analysis by Product Types
  • 9.4 India APIs Market by Customer Base
    • 9.4.1 India Synthetic Market Revenue by Customer Base and Forecasts to 2017
    • 9.4.2 India Synthetic Market Revenue Share Analysis by Customer Base
    • 9.4.3 India Biotech Market Revenue by Customer Base and Forecasts to 2017
    • 9.4.4 India Biotech Market Revenue Share Analysis by Customer Base
  • 9.5 India APIs Market Revenue Analysis by Therapeutic Applications

10 Appendix

  • 10.1 Abbreviations
  • 10.2 Market Definitions
  • 10.3 Methodology
    • 10.3.1 Coverage
    • 10.3.2 Secondary Research
    • 10.3.3 Primary Research
    • 10.3.4 Expert Panel Validation
  • 10.4 Bibliography
  • 10.5 Contact Us
  • 10.6 Disclaimer

List of Figures

  • Figure 1: APIs Market, Asia-Pacific, Revenue ($m), 2005 - 2017
  • Figure 2: APIs Market, Asia-Pacific, Revenue Share by Product Types (%), 2011
  • Figure 3: APIs Market, Asia-Pacific, Revenue Share by Countries (%), 2011
  • Figure 4: CMO Market, Global, CMO Process Selection and Outsourcing Project Management
  • Figure 5: CMO Market, Asia-Pacific, Fine Chemical Industry Labor Cost ($/Operator/Year), 2011
  • Figure 6: CMO Market, Key Benefits of CMO Outsourcing
  • Figure 7: CMO Market, Asia-Pacific, Revenue Forecasts ($m), 2005 - 2017
  • Figure 8: APIs Market, Asia-Pacific, Industry Value Chain
  • Figure 9: APIs Market, Asia-Pacific, Distribution Structure
  • Figure 10: APIs Market, Asia-Pacific, Product Types
  • Figure 11: APIs Market, Asia-Pacific, Market Revenues ($m), 2005 - 2017
  • Figure 12: APIs Market, Asia-Pacific, Revenue Share by Product Types (%), 2011
  • Figure 13: Synthetic Market, Asia-Pacific, Market Revenues ($m), 2005 - 2017
  • Figure 14: Synthetic Market, Asia-Pacific, Revenue Share Analysis by Countries (%), 2011
  • Figure 15: Synthetic Market, Asia-Pacific, Performance and Potential Analysis Grid, 2005 - 2017 3
  • Figure 16: Synthetic Market, Asia-Pacific, Revenue Analysis by Countries (%), 2005, 2011 and 2017
  • Figure 17: Synthetic Market, Asia-Pacific, Revenue Share by Customer Base (%), 2011
  • Figure 18: Synthetic Market, Asia-Pacific, Revenue Trend Analysis by Product Types ($m), 2005 - 2017
  • Figure 19: Biotech Market, Asia-Pacific, Market Revenues ($m and %), 2005 - 2017
  • Figure 20: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries (%), 2011
  • Figure 21: Biotech Market, Asia-Pacific, Performance and Potential Analysis Grid, 2005 - 2017
  • Figure 22: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries ($m), 2005, 2011 and 2017
  • Figure 23: Biotech Market, Asia-Pacific, Revenue Share Analysis by Customer Base (%), 2011
  • Figure 24: Biotech Market, Asia-Pacific, Market Revenues by Product Type ($m), 2005 - 2017
  • Figure 25: APIs Market, Asia-Pacific, Revenue Share Analysis by Therapeutic Applications (%), 2011 and 2017
  • Figure 26: APIs Market, Japan, Market Revenues by Product Types ($m), 2005 - 2017
  • Figure 27: APIs Market, Japan, Revenue Share Analysis by Product Types (%), 2005, 2011 and 2017
  • Figure 28: Synthetic Market, Japan, Market Revenues by Customer Base ($m), 2005 - 2017
  • Figure 29: Synthetic Market, Japan, Revenue Share by Customer Base (%), 2005, 2011 and 2017
  • Figure 30: Biotech Market, Japan, Market Revenues by Customer Base ($m), 2005 - 2017
  • Figure 31: Biotech Market, Japan, Revenue Share Analysis by Customer Base (%), 2005, 2011 and 2017
  • Figure 32: APIs Market, Japan, Revenue Share Analysis by Therapeutic Applications (%), 2011 - 2017
  • Figure 33: APIs Market, China, Market Revenues by Product Type ($m), 2005 - 2017
  • Figure 34: APIs Market, China, Revenue Share Analysis by Product Type (%), 2005, 2011 and 2017
  • Figure 35: Synthetic Market, China, Market Revenues by Customer Base ($m), 2005 - 2017
  • Figure 36: Synthetic Market, China, Revenue Share Analysis by Customer Base (%), 2005 - 2017
  • Figure 37: Biotech Market, China, Market Revenues by Customer Base ($m), 2005 - 2017
  • Figure 38: Biotech Market, China, Revenue Share Analysis by Customer Base (%), 2005, 2011 and 2017
  • Figure 39: APIs Market, China, Revenue Share Analysis by Therapeutic Applications (%), 2011 and 2017
  • Figure 40: APIs Market, South Korea, Market Revenues by Product Types ($m), 2005 - 2017
  • Figure 41: APIs Market, South Korea, Revenues Share Analysis by Product Types (%), 2005, 2011 and 2017
  • Figure 42: Synthetic Market, South Korea, Market Revenues by Customer Base ($m), 2005 - 2017
  • Figure 43: Synthetic Market, South Korea, Revenue Share Analysis by Customer Base (%), 2005, 2011 and 2017
  • Figure 44: Biotech Market, South Korea, Market Revenues by Customer Base ($m), 2005 - 2017
  • Figure 45: Biotech Market, South Korea, Revenue Share Analysis by Customer Base (%), 2005, 2011 and 2017
  • Figure 46: APIs Market, South Korea, Revenue Share Analysis by Therapeutic Applications (%), 2011 and 2017
  • Figure 47: APIs Market, India, Market Revenues by Product Types ($m), 2005 - 2017
  • Figure 48: APIs Market, India, Revenue Share Analysis by Product Types (%), 2005, 2011 and 2017
  • Figure 49: Synthetic Market, India, Market Revenues by Customer Base ($m), 2005 - 2017
  • Figure 50: Synthetic Market, India, Revenue Share Analysis by Customer Base (%), 2005, 2011 and 2017
  • Figure 51: Biotech Market, India, Market Revenues by Customer Base ($m), 2005 - 2017
  • Figure 52: Biotech Market, India, Revenue Share Analysis by Customer Base (%), 2005, 2011 and 2017
  • Figure 53: APIs Market, India, Revenue Share Analysis by Therapeutic Applications (%), 2011 and 2017

List of Tables

  • Table 1: CMO Market, Asia-Pacific, Fine Chemical Industry Labor Cost, $/Operator/Year, 2011
  • Table 2: CMO Market, Asia-Pacific, Revenues, $m, 2005 - 2017
  • Table 3: APIs Market, Asia-Pacific, Market Revenues, $m, 2005 - 2017
  • Table 4: APIs Market, Asia-Pacific, Revenue Share by Product Types, $m and %, 2011
  • Table 5: Synthetic Market, Asia-Pacific, Market Revenues, $m, 2005 - 2017
  • Table 6: Synthetic Market, Asia-Pacific, Revenue Share Analysis by Countries, $m and %, 2011
  • Table 7: Synthetic Market, Asia-Pacific, Revenue Analysis by Countries ($m), 2005, 2011 and 2017
  • Table 8: Synthetic Market, Asia-Pacific, Revenue Share by Customer Base, %, 2011
  • Table 9: Synthetic Market, Asia-Pacific, Market Revenues by Product Types, $m, 2005 - 2017
  • Table 10: Biotech Market, Asia-Pacific, Market Revenues, $m, 2005 - 2017
  • Table 11: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries, $m and %, 2011
  • Table 12: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries, $m, 2005, 2011 and 2017
  • Table 13: Biotech Market, Asia-Pacific, Revenue Share Analysis by Customer Base, $m and %, 2011
  • Table 14: Biotech Market, Asia-Pacific, Market Revenues by Product Type, $m, 2005 - 2017
  • Table 15: Biotech Market , Asia-Pacific, Key Patent Expiries, 2004 - 2018
  • Table 16: APIs Market, Asia-Pacific, Revenue Share Analysis by Therapeutic Applications, %, 2011 and 2017
  • Table 17: APIs Market, Japan, Market Revenues by Product Types, $m, 2005 - 2017
  • Table 18: APIs Market, Japan, Revenue Share Analysis by Product Types, %, 2005, 2011 and 2017
  • Table 19: Synthetic Market, Japan, Market Revenues by Customer Base, $m, 2005 - 2017
  • Table 20: Synthetic Market, Japan, Revenue Share by Customer Base, %, 2005, 2011 and 2017
  • Table 21: Biotech Market, Japan, Market Revenues by Customer Base, $m, 2005 - 2017
  • Table 22: Biotech Market, Japan, Revenue Share Analysis by Customer Base, %, 2005, 2011 and 2017
  • Table 23: APIs Market, Japan, Revenue Share Analysis by Therapeutic Applications, %, 2011 - 2017
  • Table 24: APIs Market, China, Market Revenues by Product Type, $m, 2005 - 2017
  • Table 25: APIs Market, China, Revenue Share Analysis by Product Type, %, 2005, 2011 and 2017
  • Table 26: Synthetic Market, China, Market Revenues by Customer Base, $m, 2005 - 2017
  • Table 27: Synthetic Market, China, Revenue Share Analysis by Customer Base, %, 2005 - 2017
  • Table 28: Biotech Market, China, Market Revenues by Customer Base, $m, 2005 - 2017
  • Table 29: Biotech Market, China, Revenue Share Analysis by Customer Base, %, 2005, 2011 and 2017
  • Table 30: APIs Market, China, Revenue Share Analysis by Therapeutic Applications, %, 2011 and 2017
  • Table 31: APIs Market, South Korea, Market Revenues by Product Types, $m, 2005 - 2017
  • Table 32: APIs Market, South Korea, Revenue Share Analysis by Product Types, %, 2005, 2011 and 2017
  • Table 33: Synthetic Market, South Korea, Market Revenues by Customer Base, $m, 2005 - 2017
  • Table 34: Synthetic Market, South Korea, Revenue Share Analysis by Customer Base, %, 2005, 2011 and 2017
  • Table 35: Biotech Market, South Korea, Market Revenues by Customer Base, $m, 2005 - 2017
  • Table 36: Biotech Market, South Korea, Revenue Share Analysis by Customer Base, %, 2005, 2011 and 2017
  • Table 37: APIs Market, South Korea, Revenue Share Analysis by Therapeutic Applications, %, 2011 and 2017
  • Table 38: APIs Market, India, Market Revenues by Product Types, $m, 2005 - 2017
  • Table 39: APIs Market, India, Revenue Share Analysis by Product Types, %, 2005, 2011 and 2017
  • Table 40: Synthetic Market, India, Market Revenues by Customer Base, $m, 2005 - 2017
  • Table 41: Synthetic Market, India, Revenue Share Analysis by Customer Base, %, 2005, 2011 and 2017
  • Table 42: Biotech Market, India, Market Revenues by Customer Base, $m, 2005 - 2017
  • Table 43: Biotech Market, India, Revenue Share Analysis by Customer Base, %, 2005, 2011 and 2017
  • Table 44: APIs Market, India, Revenue Share Analysis by Therapeutic Applications, %, 2011 and 2017
Back to Top